NCT06693882
Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.
Enrolling by Invitation
NAAges 18+InterventionalTreatmentGlaucoma Center of San FranciscoInvestigator-initiated
~50 participants
Updated 2024-11-20 on ClinicalTrials.gov
What's tested:EYETRONIC Nextwave System
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in visual field mean deviation (MD) from baseline to post-treatment
Measured over 12 months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Subjects 18 years or older who have glaucoma
Humphrey visual field mean deviation (MD) values between - 6 dB and -20 dB
Exclusion
Age \< 18 years
Implanted electronic devices
Metallic artifacts in the head (except dentures)
Migraine
Epilepsy
Brain tumor
Pregnancy
Breastfeeding patients
Uncontrolled intraocular pressure (IOP)
IOP lowering medication started less than six months before enrollment
Any intraocular surgery less than 6 months before enrollment
Arterial hypertension without appropriate treatment
Acute retinal hemorrhage
What this trial measures
- Change in visual field mean deviation (MD) from baseline to post-treatment12 months
Visual field testing will be performed with the Humphrey field analyzer (Carl Zeiss Meditec)